Clinical Trial Update: Pomalidomide, Rituximab and Orelabrutinib Combined With Polatuzumab Vedotin in the Treatment of Newly Diagnosed Elderly Patients With DLBCL [NA]

View source ↗

Summary

This clinical trial update reports a study evaluating a quadruple combo regimen of pomalidomide, rituximab, orelabrutinib, and polatuzumab vedotin for newly dia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Orelabrutinib (orelabrutinib)
• Polivy (polatuzumab vedotin)
• Pomalyst (pomalidomide)
• Rituxan (rituximab)

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: Diffuse Large B-Cell Lymphoma | NA | Status: RECRUITING